The prevalence of obstructive sleep apnoea (OSA) of individuals with Class III obesity (BMI ≥ 40) is usually over 70%.
Results: Four hundred and one patients were seen by physicians in OMS during this period and 46 patients (11.5%) had diagnostic PSG performed as they were considered to be at high risk of OSA by OMS physicians. 87% of patients referred for PSG by OMS physicians had OSA. There was also a high prevalence of multiple co-morbidities particularly anxiety/ depression, hypertension and arthritis similar to previous study. Five (10.9%) patients were previously diagnosed with OSA but not treated. 60.9% of these patients had Patient Health Questionnaire (PHQ-9) scored consistent with moderate or severe depression. The rate of smoking and alcohol consumption of OMS PSG patients was significantly lower than average Australian population of same age group. 39% of patients had subjective daytime sleepiness as measured by the Epworth Sleepiness Scale and this was not related to severity of OSA. OMS physicians did not record sleep-related symptoms in a large proportion of patients. Presence of sleep-related symptoms such as snoring, witnessed apnoea, frequency of wake and unrefreshed sleep were correlated with OSA diagnosis. Sleep latency of more than 1 h and daytime naps were not statistically related to OSA.
Conclusions:
This study showed that OMS physicians often did not record sleep-related symptoms and refer only a small proportion of the patient cohort for PSG. The prevalence of OSA is high in patients with Class III obesity and routine screening for sleep-related symptoms and referral for PSG where appropriate is recommended. Routine application of OSA symptom questionnaire such as OSA-50 or STOP-Bang may also be of value in this clinical setting. Background: Pleural diseases are one of the most common clinical problems encountered worldwide. Large-bore (LB) intercostal tube (ICT; e.g. >20 F) drainage has been the standard of care in the management of pleural diseases for several decades. More recently small-bore (SB) intercostal catheters (ICC; e.g. 10-14 F) have gained acceptance as an alternative to LB ICTs. 1 However, the choice of the ICT/ICC size in the management of patients presenting acutely with pleural effusion or pneumothorax remains controversial.
SMALL BORE INTERCOSTAL CATHETERS ARE AS EFFICIENT AS LARGE BORE INTERCOSTAL TUBES WITH BETTER PATIENT TOLERANCE

Aims:
The purpose of this study was to evaluate our current practice and to access the efficacy of SB ICCs (10-14 F) versus LB ICTs (>20 F) in the management of pleural diseases.
Settings: Tertiary teaching hospital.
Design: Prospective non-randomised audit.
Methods and Material:
A total of 52 patients (42 males) with a mean age of 55 AE 23 years undergoing pleural intervention were included in the analysis. Initial treatment success was defined as complete resolution of effusion or pneumothorax without ICT/ICC kinking, obstruction, displacement or needing second intervention such as placement of a second ICT/ICC or surgery. 27 patients underwent SB ICC (mean age 63 AE 19 years) and 25 underwent LB ICT (mean age 46 AE 24 years).
Results: A trend towards inserting SB ICCs in patients with primary pleural effusion and LB ICT drains in patients presenting with pneumothorax was noted.
Success rate of SB ICC and LB ICTs was 74% and 76% respectively. Drain failure or second intervention to achieve successful outcome in patients with SB ICCs was predominantly related to loculated effusion and persistent air leak secondary to pneumothorax while drain failure in patients with LB ICTs was predominantly related to partial or complete dislodgement of the chest drain; particularly during inter-hospital transfer or persistent air leak. In both groups, no deaths or major complications directly related to the procedure were observed.
The ICC dwell time was lesser in SB ICC (6 AE 4 days) versus LB ICT (8 AE 6 days). SB ICCs were associated with less pain and seem to be tolerated better by the patients.
Conclusions:
Our study suggests that SB ICCs are as efficient as LB ICTs with better patient tolerance and less dwell time. The results are similar to previous studies which have reported similar success, complications rates, dwell time and patient tolerance. 2, 3 
